PCAT18 and prostate carcinoma: For example, the level of long non-coding RNA-activated by transforming growth factor β (ATB) was increased by 5–10-fold in glioma patients, while that of a metastatic prostate cancer-related lncRNA PCAT18 was reported to be elevated by 8.8–11-fold in prostate cancer cells [152].